Skip to content
Recall Observatory FDA recall evidence

Drug product

TACROLIMUS 0.03% OPH SOLUTION TACROLIMUS 0.1% (1ML DROPTAINER) OPH SOLUTION TACROLIMUS -CORN OIL- 0.03% OPH SOLUTION TACROLIMUS-VET- 0.02% (10ML DROPPER) OPHTHALMIC TACROLIMUS-VET- 0.02% (15ML DROPPER) OPHTHALMIC TACROLIMUS-VET- 0.02% (5ML DROPPER) OPHTHALMIC TACROLIMUS-VET- 0.03% (10ML DROPPER) OPHTHALMIC, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

D-0237-2023

December 22, 2022

Class II

Product summary

Firm
Pharmacy Innovations
Event
Event 91332
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0237-2023

Official wording

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Code information: t20221011@25 t20221011@55 t20221020@26 t20221104@44 t20221027@6 20221019@44 t20221026@41

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility